PLAAT3 and pancreatic neoplasm: To further substantiate the potential impact of PLA2G16 on the proliferation and gemcitabine resistance in pancreatic cancer cells, PLA2G16 knockdown was conducted on PANC-1/GR cells using siRNA-PLA2G16.